• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

加拿大卑诗省宫颈上皮内瘤变发病率的下降:基于学校的人乳头瘤病毒疫苗接种计划效果的生态学分析。

Declining rates of cervical intraepithelial neoplasia in British Columbia, Canada: An ecological analysis on the effects of the school-based human papillomavirus vaccination program.

机构信息

Vaccine Evaluation Center, BC Children's Hospital Research Institute, Vancouver, British Columbia, Canada.

Women's Health Research Institute, BC Women's Hospital and Health Service, Vancouver, British Columbia, Canada.

出版信息

Int J Cancer. 2021 Jul 1;149(1):191-199. doi: 10.1002/ijc.33513. Epub 2021 Feb 26.

DOI:10.1002/ijc.33513
PMID:33586169
Abstract

Since 2008, girls in British Columbia (BC), Canada, have been offered HPV vaccination through a school-based, publicly funded immunization program. The oldest birth cohort eligible for the vaccination program was born in 1994 and uptake is on average 63%. To evaluate the impact of the HPV vaccine in BC, ecological trends in cervical intraepithelial neoplasia (CIN) rates were assessed in young women before and after the implementation of the HPV vaccination program. Information on all Pap smears and histopathological abnormalities, in calendar years 2004-2017 in women 16-28 years of age in BC were obtained from the population-based BC Cancer Cervix Screening Program database. Rates of CIN 2 and 3 were calculated as the number of cases divided by the number of cytology specimens for that period. Rate ratios (RR) were calculated by negative binomial piecewise regression. Age-centered incidence rates of CIN 2 and 3 in BC declined significantly among women 16-23 years of age after HPV vaccine introduction compared to before vaccine introduction. The overall reduction postvaccination for CIN2 and 3 in women 16-23 years was respectively 62% (95% CI 54-68%) and 65% (95% CI 58-71%). Age-specific rates for CIN2 significantly declined for those 18-22 years of age and for those 19, 20 and 23 years of age for CIN3. Among women 24-28 years of age no decline in CIN2 and 3 rate over time was observed. The observed reduction in CIN 2 and 3 rates since the introduction of the school-based HPV vaccine program might illustrate the population impact of the BC provincial school-based HPV vaccination program.

摘要

自 2008 年以来,加拿大不列颠哥伦比亚省(BC)的女孩通过基于学校的公共资助免疫计划接种 HPV 疫苗。有资格接种该疫苗的最年长出生队列出生于 1994 年,接种率平均为 63%。为了评估 HPV 疫苗在 BC 的影响,在 HPV 疫苗接种计划实施前后,评估了年轻女性中宫颈上皮内瘤变(CIN)率的生态趋势。BC 癌症宫颈筛查计划数据库获得了 2004-2017 年 BC 16-28 岁女性所有巴氏涂片和组织病理学异常的信息。CIN 2 和 3 的发病率计算为该时期病例数除以细胞学标本数。通过负二项式分段回归计算率比(RR)。与疫苗接种前相比,HPV 疫苗接种后,16-23 岁女性的 CIN 2 和 3 发病率明显下降。16-23 岁女性接种疫苗后,CIN2 和 3 的总体降幅分别为 62%(95%CI 54-68%)和 65%(95%CI 58-71%)。18-22 岁和 19、20 和 23 岁女性的 CIN2 年龄特异性发病率显著下降。在 24-28 岁的女性中,CIN2 和 3 的发病率没有随时间下降。自基于学校的 HPV 疫苗计划实施以来,CIN 2 和 3 发病率的下降可能表明了 BC 省级学校 HPV 疫苗接种计划对人群的影响。

相似文献

1
Declining rates of cervical intraepithelial neoplasia in British Columbia, Canada: An ecological analysis on the effects of the school-based human papillomavirus vaccination program.加拿大卑诗省宫颈上皮内瘤变发病率的下降:基于学校的人乳头瘤病毒疫苗接种计划效果的生态学分析。
Int J Cancer. 2021 Jul 1;149(1):191-199. doi: 10.1002/ijc.33513. Epub 2021 Feb 26.
2
Reduction in cervical intraepithelial neoplasia in young women in British Columbia after introduction of the HPV vaccine: An ecological analysis.引入人乳头瘤病毒(HPV)疫苗后不列颠哥伦比亚省年轻女性宫颈上皮内瘤变的减少:一项生态学分析
Int J Cancer. 2015 Oct 15;137(8):1931-7. doi: 10.1002/ijc.29508. Epub 2015 Jun 3.
3
Cervical Intraepithelial Neoplasia Rates in British Columbia Women: A Population-Level Data Linkage Evaluation of the School-Based HPV Immunization Program.不列颠哥伦比亚省女性的宫颈上皮内瘤变发生率:基于人群的 HPV 免疫接种计划的学校数据链接评估。
J Infect Dis. 2020 Jan 1;221(1):81-90. doi: 10.1093/infdis/jiz422.
4
Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.接种人乳头瘤病毒预防性疫苗以预防宫颈癌及其癌前病变。
Cochrane Database Syst Rev. 2018 May 9;5(5):CD009069. doi: 10.1002/14651858.CD009069.pub3.
5
Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis.人群水平影响和 herd 效应:人乳头瘤病毒疫苗接种计划引入后的更新系统评价和荟萃分析。
Lancet. 2019 Aug 10;394(10197):497-509. doi: 10.1016/S0140-6736(19)30298-3. Epub 2019 Jun 26.
6
The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.英格兰原发性人乳头瘤病毒子宫颈筛查的临床效果和成本效益:通过三轮筛查对 ARTISTIC 随机试验队列进行的扩展随访。
Health Technol Assess. 2014 Apr;18(23):1-196. doi: 10.3310/hta18230.
7
Ten-year follow-up of human papillomavirus vaccine efficacy against the most stringent cervical neoplasia end-point-registry-based follow-up of .人乳头瘤病毒疫苗针对最严格的宫颈肿瘤终点(基于登记处的随访)的十年随访
BMJ Open. 2017 Aug 18;7(8):e015867. doi: 10.1136/bmjopen-2017-015867.
8
Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women.人乳头瘤病毒(HPV)-6/11/16/18 疫苗对年轻女性所有 HPV 相关生殖器疾病的影响。
J Natl Cancer Inst. 2010 Mar 3;102(5):325-39. doi: 10.1093/jnci/djp534. Epub 2010 Feb 5.
9
The impact of Germany's human papillomavirus immunization program on HPV-related anogenital diseases: a retrospective analysis of claims data from statutory health insurances.德国 HPV 疫苗免疫计划对 HPV 相关肛门生殖器疾病的影响:来自法定健康保险索赔数据的回顾性分析。
Arch Gynecol Obstet. 2024 Nov;310(5):2639-2646. doi: 10.1007/s00404-024-07692-y. Epub 2024 Sep 4.
10
The impact of bivalent HPV vaccine on cervical intraepithelial neoplasia by deprivation in Scotland: reducing the gap.苏格兰二价人乳头瘤病毒疫苗对因疫苗接种不足导致的宫颈上皮内瘤变的影响:缩小差距
J Epidemiol Community Health. 2017 Oct;71(10):954-960. doi: 10.1136/jech-2017-209113. Epub 2017 Jul 29.

引用本文的文献

1
Impact of human papillomavirus vaccines in the reduction of infection, precursor lesions, and cervical cancer: A systematic literature review.人乳头瘤病毒疫苗在减少感染、癌前病变和宫颈癌方面的影响:一项系统文献综述。
Hum Vaccin Immunother. 2025 Dec;21(1):2497608. doi: 10.1080/21645515.2025.2497608. Epub 2025 Jun 9.
2
Canadian Guideline on the Management of a Positive Human Papillomavirus Test and Guidance for Specific Populations.加拿大人乳头瘤病毒阳性检测管理指南及特定人群指导意见。
Curr Oncol. 2023 Jun 9;30(6):5652-5679. doi: 10.3390/curroncol30060425.